Becton, Dickinson, and Company announced the results of a peer-reviewed study. The peer-reviewed study was conducted to reduce hazardous drug surface contamination.
Merck KGaA signed a non-binding Memorandum of Understanding (MoU) with Synplogen. Both companies are noticed to focus on manufacturing and testing for viral vector gene therapies for Japan.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?